| # | Title | Journal | Year | Citations |
|---|
| 1 | Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk | Nature Genetics | 2019 | 1,625 |
| 2 | New insights into the genetic etiology of Alzheimer’s disease and related dementias | Nature Genetics | 2022 | 700 |
| 3 | The characterisation of subjective cognitive decline | Lancet Neurology, The | 2020 | 627 |
| 4 | Brain charts for the human lifespan | Nature | 2022 | 518 |
| 5 | Blood-based biomarkers for Alzheimer's disease: towards clinical implementation | Lancet Neurology, The | 2022 | 360 |
| 6 | Cortico-hippocampal communication by way of parallel parahippocampal-subicular pathways | Hippocampus | 2000 | 323 |
| 7 | Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell | Annals of Neurology | 2001 | 288 |
| 8 | Shunting normal‐pressure hydrocephalus: Do the benefits outweigh the risks? | Neurology | 1992 | 279 |
| 9 | Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias | Lancet Neurology, The | 2020 | 254 |
| 10 | Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia | Brain | 2007 | 232 |
| 11 | Subjective cognitive decline and rates of incident Alzheimer's disease and non–Alzheimer's disease dementia | Alzheimer's and Dementia | 2019 | 232 |
| 12 | A meta-analysis of genome-wide association studies identifies multiple longevity genes | Nature Communications | 2019 | 214 |
| 13 | The clinical promise of biomarkers of synapse damage or loss in Alzheimer’s disease | Alzheimer's Research and Therapy | 2020 | 183 |
| 14 | Within-Subject Reproducibility of Visual Activation Patterns With Functional Magnetic Resonance Imaging Using Multislice Echo Planar Imaging | Magnetic Resonance Imaging | 1998 | 163 |
| 15 | Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders | Brain | 2020 | 158 |
| 16 | Pathophysiologic Mechanisms in the Development of Age-Related White Matter Changes of the Brain | Dementia and Geriatric Cognitive Disorders | 1998 | 156 |
| 17 | What electrophysiology tells us about Alzheimer's disease: a window into the synchronization and connectivity of brain neurons | Neurobiology of Aging | 2020 | 150 |
| 18 | Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease | JAMA Neurology | 2021 | 148 |
| 19 | Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores | Nature Communications | 2021 | 140 |
| 20 | Visual association encoding activates the medial temporal lobe: A functional magnetic resonance imaging study | Hippocampus | 1997 | 134 |
| 21 | Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology | Alzheimer's Research and Therapy | 2020 | 129 |
| 22 | Interictal and Postictal Cognitive Changes in Migraine | Cephalalgia | 1999 | 128 |
| 23 | Global Prevalence of Young-Onset Dementia | JAMA Neurology | 2021 | 124 |
| 24 | Long-term experience with intraoperative microrecording during DBS neurosurgery in STN and GPi | Acta Neurochirurgica | 2010 | 115 |
| 25 | Motor consequences of experimentally induced limb pain: A systematic review | European Journal of Pain | 2013 | 103 |
| 26 | Cerebrospinal fluid biomarkers of white matter lesions – cross‐sectional results from the LADIS study | European Journal of Neurology | 2010 | 100 |
| 27 | Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum | JAMA Neurology | 2022 | 97 |
| 28 | Practical benefit of [123I]FP-CIT SPET in the demonstration of the dopaminergic deficit in Parkinson's disease | European Journal of Nuclear Medicine and Molecular Imaging | 1997 | 94 |
| 29 | Drug treatment of Parkinson’s disease | Biochemical Pharmacology | 2000 | 93 |
| 30 | Developing retinal biomarkers for the earliest stages of Alzheimer's disease: What we know, what we don't, and how to move forward | Alzheimer's and Dementia | 2020 | 92 |
| 31 | The RANO Leptomeningeal Metastasis Group proposal to assess response to treatment: lack of feasibility and clinical utility and a revised proposal | Neuro-Oncology | 2019 | 90 |
| 32 | Pathophysiological subtypes of Alzheimer’s disease based on cerebrospinal fluid proteomics | Brain | 2020 | 89 |
| 33 | Subjective Cognitive Impairment Cohort (SCIENCe): study design and first results | Alzheimer's Research and Therapy | 2018 | 87 |
| 34 | A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity | Acta Neuropathologica | 2019 | 87 |
| 35 | Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231 | Alzheimer's Research and Therapy | 2021 | 87 |
| 36 | Age dependency of risk factors for cognitive decline | BMC Geriatrics | 2018 | 85 |
| 37 | Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study | Lancet Neurology, The | 2019 | 85 |
| 38 | Serum markers glial fibrillary acidic protein and neurofilament light for prognosis and monitoring in cognitively normal older people: a prospective memory clinic-based cohort study | The Lancet Healthy Longevity | 2021 | 85 |
| 39 | The use of PROMs and shared decision‐making in medical encounters with patients: An opportunity to deliver value‐based health care to patients | Journal of Evaluation in Clinical Practice | 2020 | 82 |
| 40 | Neuroimaging in Functional Neurological Disorder: State of the Field and Research Agenda | NeuroImage: Clinical | 2021 | 79 |
| 41 | Quality of life in multiple sclerosis: The disability and impact profile (DIP) | Journal of Neurology | 1996 | 76 |
| 42 | A clinical-radiological framework of the right temporal variant of frontotemporal dementia | Brain | 2020 | 76 |
| 43 | Exploring differences between subgroups of multiple sclerosis patients in health-related quality of life | Journal of Neurology | 1999 | 75 |
| 44 | Does change in health-related quality of life score predict survival? Analysis of EORTC 08975 lung cancer trial | British Journal of Cancer | 2014 | 74 |
| 45 | Reproducibility of EEG functional connectivity in Alzheimer’s disease | Alzheimer's Research and Therapy | 2020 | 73 |
| 46 | CSF or Serum Neurofilament Light Added to α‐Synuclein Panel Discriminates Parkinson's From Controls | Movement Disorders | 2020 | 69 |
| 47 | Human brain connectivity: Clinical applications for clinical neurophysiology | Clinical Neurophysiology | 2020 | 68 |
| 48 | Impact of the COVID-19 outbreak on acute stroke care | Journal of Neurology | 2021 | 68 |
| 49 | Magnetic Resonance Imaging Predictors of Cognition in Mild Cognitive Impairment | Archives of Neurology | 2007 | 67 |
| 50 | Lymphocytic hypophysitis | World Neurosurgery | 1987 | 65 |
